Department of Biomedical Sciences, Sri Ramachandra Institute of Higher Education and Research, Chennai, India.
J Wound Care. 2020 Dec 1;29(Sup12):S38-S43. doi: 10.12968/jowc.2020.29.Sup12.S38.
The purpose of this study was to identify the potential of resveratrol in inhibiting the growth and production of two enzymes, hyaluronidase and protease, in , which has become a burn wound pathogen of great significance.
(ATCC 17666) was cultured in nutrient broth and the microbial load was standardised to 0.5 McFarland standard at 600nm. The study included antimicrobial assays (well diffusion and resazurin dye binding method), hyaluronidase expression regulation assay (hyaluronic acid hydrolysis assay and turbidity assay) and protease expression regulation assay (casein hydrolysis assay and determination of specific activity of protease using tyrosine standard).
The minimum inhibitory concentration (MIC) of resveratrol against was found to be 125µg/ml. Hyaluronidase production in the organism treated with resveratrol was found to be half that in the untreated organism. The specific activity of protease produced by the organism treated with resveratrol was found to be one-quarter that in the untreated organism, as analysed by the tyrosine standard estimation protocol.
Resveratrol was found to be a potent compound to treat infections. In addition to the antimicrobial and enzyme-regulatory properties of resveratrol, it also shows anti-oxidant and anti-inflammatory properties. This finding has great scope clinically as resveratrol may prove to be an ideal drug to treat burn wound infections.
本研究旨在探讨白藜芦醇抑制两种酶(透明质酸酶和蛋白酶)生长和产生的潜力,这两种酶已成为具有重要意义的烧伤创面病原体。
将(ATCC 17666)在营养肉汤中培养,并将微生物负荷标准化为 600nm 处 0.5 McFarland 标准。本研究包括抗菌测定(孔扩散和 Resazurin 染料结合法)、透明质酸酶表达调控测定(透明质酸水解测定和浊度测定)和蛋白酶表达调控测定(酪蛋白水解测定和使用酪氨酸标准测定蛋白酶的比活)。
发现白藜芦醇对的最小抑菌浓度(MIC)为 125µg/ml。用白藜芦醇处理的生物体内透明质酸酶的产生量发现是未处理生物体内的一半。用白藜芦醇处理的生物体内产生的蛋白酶的比活通过酪氨酸标准估计方案发现为未处理生物体内的四分之一。
白藜芦醇被发现是一种治疗的有效化合物。除了白藜芦醇的抗菌和酶调节特性外,它还具有抗氧化和抗炎特性。这一发现具有很大的临床应用前景,因为白藜芦醇可能被证明是治疗烧伤创面感染的理想药物。